AFP and neoplasm: OS time was longer in patients with an AFP level ≤ 400 IU/mL than an AFP level > 400 IU/mL (11.13 months vs. 5.20 months, P = 0.022), in patients with a tumor size ≤ 5 cm than a tumor size > 5 cm (29.27 months vs. 5.87 months, P = 0.002), in patients without ascites than with ascites (8.97 months vs. 5.00 months, P = 0.049), and in patients without tumor thrombus than with tumor thrombus (11.37 months vs. 5.00 months, P = 0.005).